Literature DB >> 22246793

Epithelial-to-mesenchymal transition induced by Freund's adjuvant treatment in rat mesothelial cells: a morphological and immunocytochemical study.

Sándor Katz1, Petra Balogh, Nándor Nagy, Anna L Kiss.   

Abstract

Intraperitoneal injection of Freund's adjuvant induces acute peritonitis. By the time of the Freund's adjuvant treatment the flat, simple squamous epithelial cells became rounded, cuboidal shaped, many of them have lost their connection with the neighbouring cells and detached from the basement membrane. The macrophage markers' (ED1, OX43 and CD68) expression also increased in the mesothelial cells and more mesothelin and anti-ED1 double-labelled cells were found freely present close to the surface. The cytokeratin expression of the mesothelial cells has gradually decreased. At the 5th day of the inflammation practically there was no cytokeratin labelling present in the mesothelial cells and the mesothelin expression has significantly decreased. Parallel to this mesothelial cells started to express vimentin, a characteristic mesenchymal intermediate filament protein indicating that they gradually lost their epithelial character and gained mesenchymal phenotype. These results strongly suggest that under the effect of Freund's adjuvant treatment (inflammation) mesothelial cells can undergo epithelial-to-mesenchymal transition and differentiate into phagocytotic (macrophage-like) cells. Studying the caveolae/caveolin-1 on the plasma membrane of mesothelial cells we found that the Freund's adjuvant treatment has changed the cellular distribution of caveolin-1: as the inflammation progressed strong caveolin-1 labelling was found inside of the cytoplasm (in perinuclear localization) indicating that inflammation induced the caveolae internalization. These results indicate that caveolae/caveolin-1 might play important regulatory role in signal transduction leading to trasdifferentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246793     DOI: 10.1007/s12253-011-9489-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 2.  Caveolins: structure and function in signal transduction.

Authors:  Wanda M Krajewska; Izabela Masłowska
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

3.  Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor.

Authors:  B Razani; X L Zhang; M Bitzer; G von Gersdorff; E P Böttinger; M P Lisanti
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 4.  Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation.

Authors:  Aristidis Moustakas; Katerina Pardali; Annamaria Gaal; Carl Henrik Heldin
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

5.  Inhibition of invasion of epithelial cells by Tiam1-Rac signaling.

Authors:  P L Hordijk; J P ten Klooster; R A van der Kammen; F Michiels; L C Oomen; J G Collard
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

Review 6.  Nestin expression--a property of multi-lineage progenitor cells?

Authors:  C Wiese; A Rolletschek; G Kania; P Blyszczuk; K V Tarasov; Y Tarasova; R P Wersto; K R Boheler; A M Wobus
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

7.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

8.  TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.

Authors:  E Piek; A Moustakas; A Kurisaki; C H Heldin; P ten Dijke
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

9.  The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts.

Authors:  V M Braga; L M Machesky; A Hall; N A Hotchin
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

10.  p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

Authors:  Andrei V Bakin; Cammie Rinehart; Anne K Tomlinson; Carlos L Arteaga
Journal:  J Cell Sci       Date:  2002-08-01       Impact factor: 5.285

View more
  5 in total

1.  Inflammation-Induced Epithelial-to-Mesenchymal Transition and GM-CSF Treatment Stimulate Mesenteric Mesothelial Cells to Transdifferentiate into Macrophages.

Authors:  Sándor Katz; Viktória Zsiros; Nikolett Dóczi; Anna L Kiss
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  GM-CSF and GM-CSF receptor have regulatory role in transforming rat mesenteric mesothelial cells into macrophage-like cells.

Authors:  Sándor Katz; Viktória Zsiros; Nikolett Dóczi; Arnold Szabó; Ádám Biczó; Anna L Kiss
Journal:  Inflamm Res       Date:  2016-06-30       Impact factor: 4.575

3.  Estrogen receptor alpha is expressed in mesenteric mesothelial cells and is internalized in caveolae upon Freund's adjuvant treatment.

Authors:  Petra Balogh; Arnold Szabó; Sándor Katz; István Likó; Attila Patócs; Anna L Kiss
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

Review 4.  Cellular and molecular events of inflammation induced transdifferentiation (EMT) and regeneration (MET) in mesenteric mesothelial cells.

Authors:  Viktória Zsiros; Anna L Kiss
Journal:  Inflamm Res       Date:  2020-09-12       Impact factor: 4.575

Review 5.  Inflammation in Focus: The Beginning and the End.

Authors:  Anna L Kiss
Journal:  Pathol Oncol Res       Date:  2022-01-04       Impact factor: 3.201

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.